CCL2 and Alzheimer disease: Egger's regression test found potentially significant publication bias (p < 0.05) for serum measures of IL1β and IL18 and CSF MCP-1 in studies including AD and HC participants (Table 1), as well as serum and plasma measures of IL1α in studies of MCI and HC participants (Supplementary Material 1 Table s5).